Latest filing published 11 Mar 2024 for Harpoon Therapeutics, Inc..
No signal scores available.
Frank J. Lanza is a declared insider of Harpoon Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 26 November 2023 and the latest from 11 March 2024.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 11 March 2024 came the latest disclosure, a transaction in Harpoon Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations